-purchase income Other income 1,867 2,920 148 559 1,738 3,076 249 593 -7% 5% 69% 6% Total Revenues 5,494 5,656 3% Operating and administrative expenses and others Bad debts and doubtful accounts Finance costs
151.10 million from the second quarter of the year 2019 of Baht 84.28 million or -55.78% from lower salary and employee benefits. Finance costs Finance costs of the second quarter of the year 2020 of Baht
) (13.54%) Finance Cost 7.34 9.28 (1.94) (20.91%) 24.27 29.23 (4.96) (16.96%) EBT 64.28 3.20 61.08 1,907.28% 166.91 104.68 62.23 59.45% Tax 1.56 (0.62) 2.18 (351.08%) (4.78) (20.90) 16.12 77.14% Net Profit
loss Finance costs Other expenses 2,337 1,872 560 26 2,056 1,345 515 8 2,160 883 469 2 5% -34% -9% -75% -8% -53% -16% -92% 9,263 6,646 2,209 39 8,303 6,210 2,096 46 -10% -7% -5% 18% Total Expenses 4,795
% 11,040 10,386 -6% Operating and administrative expenses Expected credit loss Finance costs Other expenses 2,003 1,590 554 21 1,921 1,226 453 2 1,974 2,005 448 6 3% 64% -1% 200% -1% 26% -19% -71% 4,086
-0.3% 21,302 20,791 -2% 19,455 19,717 1% Operating and administrative expenses Expected credit loss Finance costs Other expenses 1,987 1,619 418 3 2% -9% -2% 200% 8,303 6,210 2,096 46 7,832 6,629 1,745
% -22% 11% Total Revenues 5,820 12% 15,597 16,780 8% 14,872 15,945 7% Operating and administrative expenses Expected credit loss Finance costs Other expenses 2,039 1,884 475 0 5% 6% 12% 0% 5,846 5,011
listed company 1. To increase efficiency and reduce the cost of transportation of products in the group companies 2. To increase more business channel in the group companies. 3. To gain dividend from
99,999,800. In order to let the Company increase opportunity and channel in contributing value added to medical service business from the Company as being supporter of medical engineering for dialysis unit and